1 |
F8
| [1] Complement and coagulation cascades Complement and coagulation cascades | D00291
D00291
|
Desmopressin
| [4] 72 72, 75, 225, 288 |
2 |
GLP1R
| [3] cAMP signaling pathway cAMP signaling pathway, Neuroactive ligand-receptor interaction, Insulin secretion | D04121
D04121
|
Exenatide
| [6] 6 6, 17, 72, 78, 193, 233 |
3 |
MTNR1A
| [2] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Circadian entrainment | D08170
D08170
|
Melatonin
| [12] 6 6, 8, 13, 37, 46, 49, 72, 78, 90, 97, 145, 202 |
4 |
MTNR1B
| [2] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Circadian entrainment | D08170
D08170
|
Melatonin
| [12] 6 6, 8, 13, 37, 46, 49, 72, 78, 90, 97, 145, 202 |
5 |
OXTR
| [4] Calcium signaling pathway Calcium signaling pathway, cAMP signaling pathway, Neuroactive ligand-receptor interaction, Oxytocin signaling pathway | D00089
D00089
|
Oxytocin
| [7] 6 6, 72, 127, 168, 193, 206, 226 |
6 |
AVPR2
| [3] Phospholipase D signaling pathway Phospholipase D signaling pathway, Neuroactive ligand-receptor interaction, Vasopressin-regulated water reabsorption | D00291
D00291
|
Desmopressin
| [6] 6 6, 64, 72, 75, 225, 288 |
7 |
AVPR2
| [3] Phospholipase D signaling pathway Phospholipase D signaling pathway, Neuroactive ligand-receptor interaction, Vasopressin-regulated water reabsorption | D01213
D01213
|
Tolvaptan
| [4] 67 67, 72, 86, 225 |
8 |
SLC5A2
| - | D10459
D10459
|
Empagliflozin
| [3] 72 72, 97, 257 |